| Package | hl7.fhir.us.pq-cmc-fda |
| Type | ValueSet |
| Id | Id |
| FHIR Version | R5 |
| Source | http://hl7.org/fhir/us/pq-cmc-fda/https://build.fhir.org/ig/HL7/FHIR-us-pq-cmc-fda/ValueSet-cmc-comp-section-types-vs.html |
| Url | http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/cmc-comp-section-types-vs |
| Version | 2.0.0 |
| Status | active |
| Date | 2025-06-19T20:23:28+00:00 |
| Name | CmcCompSectionTypesVS |
| Title | eCTD sections Terminology |
| Experimental | False |
| Realm | us |
| Authority | hl7 |
| Description | Value set of all codes in Code system PQCMC Comp Section Types. |
No resources found
| CodeSystem | |
http://terminology.hl7.org/CodeSystem/ICHContextOfUse  | ICH Context of Use |
| http://terminology.hl7.org/CodeSystem/ICHContextOfUse | ICH Context of Use |
Note: links and images are rebased to the (stated) source
Generated Narrative: ValueSet cmc-comp-section-types-vs
FHIRhttp://terminology.hl7.org/CodeSystem/ICHContextOfUse| Code | Display |
| ich_3.2.s | m3.2.s drug substance |
| ich_3.2.s.1 | m3.2.s.1 general information |
| ich_3.2.s.2 | m3.2.s.2 manufacture |
| ich_3.2.s.2.1 | m3.2.s.2.1 manufacturer(s) |
| ich_3.2.s.2.2 | m3.2.s.2.2 description of manufacturing process and process controls |
| ich_3.2.s.2.3 | m3.2.s.2.3 control of materials |
| ich_3.2.s.2.4 | m3.2.s.2.4 controls of critical steps and intermediates |
| ich_3.2.s.2.5 | m3.2.s.2.5 process validation and/or evaluation |
| ich_3.2.s.2.6 | m3.2.s.2.6 manufacturing process development |
| ich_3.2.s.3 | m3.2.s.3 characterisation |
| ich_3.2.s.3.1 | m3.2.s.3.1 elucidation of structure and other characteristics |
| ich_3.2.s.3.2 | m3.2.s.3.2 impurities |
| ich_3.2.s.4 | m3.2.s.4 control of drug substance |
| ich_3.2.s.4.1 | m3.2.s.4.1 specification |
| ich_3.2.s.4.2 | m3.2.s.4.2 analytical procedures |
| ich_3.2.s.4.3 | m3.2.s.4.3 validation of analytical procedures |
| ich_3.2.s.4.4 | m3.2.s.4.4 batch analyses |
| ich_3.2.s.4.5 | m3.2.s.4.5 justification of specification |
| ich_3.2.s.5 | m3.2.s.5 reference standards or materials |
| ich_3.2.s.6 | m3.2.s.6 container closure system |
| ich_3.2.s.7 | m3.2.s.7 stability |
| ich_3.2.s.7.1 | m3.2.s.7.1 stability summary and conclusions |
| ich_3.2.s.7.2 | m3.2.s.7.2 post-approval stability protocol and stability commitment |
| ich_3.2.s.7.3 | m3.2.s.7.3 stability data |
| ich_3.2.p | m3.2.p drug product |
| ich_3.2.p.1 | m3.2.p.1 description and composition of the drug product |
| ich_3.2.p.2 | m3.2.p.2 pharmaceutical development |
| ich_3.2.p.2.1 | m3.2.p.2.1 components of the drug product |
| ich_3.2.p.2.2 | m3.2.p.2.2 drug product |
| ich_3.2.p.2.3 | m3.2.p.2.3 manufacturing process development |
| ich_3.2.p.2.4 | m3.2.p.2.4 container closure system |
| ich_3.2.p.2.5 | m3.2.p.2.5 microbiological attributes |
| ich_3.2.p.2.6 | m3.2.p.2.6 compatibility |
| ich_3.2.p.3 | m3.2.p.3 manufacture |
| ich_3.2.p.3.1 | m3.2.p.3.1 manufacturer(s) |
| ich_3.2.p.3.2 | m3.2.p.3.2 batch formula |
| ich_3.2.p.3.3 | m3.2.p.3.3 description of manufacturing process and process controls |
| ich_3.2.p.3.4 | m3.2.p.3.4 controls of critical steps and intermediates |
| ich_3.2.p.3.5 | m3.2.p.3.5 process validation and/or evaluation |
| ich_3.2.p.4 | m3.2.p.4 control of excipients |
| ich_3.2.p.4.1 | m3.2.p.4.1 specifications |
| ich_3.2.p.4.2 | m3.2.p.4.2 analytical procedures |
| ich_3.2.p.4.3 | m3.2.p.4.3 validation of analytical procedures |
| ich_3.2.p.4.4 | m3.2.p.4.4 justification of specifications |
| ich_3.2.p.4.5 | m3.2.p.4.5 excipients of human or animal origin |
| ich_3.2.p.4.6 | m3.2.p.4.6 novel excipients |
| ich_3.2.p.5 | m3.2.p.5 control of drug product |
| ich_3.2.p.5.1 | m3.2.p.5.1 specification(s) |
| ich_3.2.p.5.2 | m3.2.p.5.2 analytical procedures |
| ich_3.2.p.5.3 | m3.2.p.5.3 validation of analytical procedures |
| ich_3.2.p.5.4 | m3.2.p.5.4 batch analyses |
| ich_3.2.p.5.5 | m3.2.p.5.5 characterisation of impurities |
| ich_3.2.p.5.6 | m3.2.p.5.6 justification of specifications |
| ich_3.2.p.6 | m3.2.p.6 reference standards or materials |
| ich_3.2.p.7 | m3.2.p.7 container closure system |
| ich_3.2.p.8 | m3.2.p.8 stability |
| ich_3.2.p.8.1 | m3.2.p.8.1 stability summary and conclusion |
| ich_3.2.p.8.2 | m3.2.p.8.2 post-approval stability protocol and stability commitment |
| ich_3.2.p.8.3 | m3.2.p.8.3 stability data |
| ich_3.2.a | m3.2.a appendices |
| ich_3.2.a.1 | m3.2.a.1 facilities and equipment |
| ich_3.2.a.2 | m3.2.a.2 adventitious agents safety evaluation |
| ich_3.2.a.3 | m3.2.a.3 excipients |
| ich_3.2.r | m3.2 r regional information |
| ich_3.3 | m3.3 literature references |
{
"resourceType" : "ValueSet",
"id" : "cmc-comp-section-types-vs",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet cmc-comp-section-types-vs</b></p><a name=\"cmc-comp-section-types-vs\"> </a><a name=\"hccmc-comp-section-types-vs\"> </a><ul><li>Include these codes as defined in <a href=\"http://terminology.hl7.org/6.4.0/CodeSystem-ICHContextOfUse.html\"><code>http://terminology.hl7.org/CodeSystem/ICHContextOfUse</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>ich_3.2.s</td><td>m3.2.s drug substance</td></tr><tr><td>ich_3.2.s.1</td><td>m3.2.s.1 general information</td></tr><tr><td>ich_3.2.s.2</td><td>m3.2.s.2 manufacture</td></tr><tr><td>ich_3.2.s.2.1</td><td>m3.2.s.2.1 manufacturer(s)</td></tr><tr><td>ich_3.2.s.2.2</td><td>m3.2.s.2.2 description of manufacturing process and process controls</td></tr><tr><td>ich_3.2.s.2.3</td><td>m3.2.s.2.3 control of materials</td></tr><tr><td>ich_3.2.s.2.4</td><td>m3.2.s.2.4 controls of critical steps and intermediates</td></tr><tr><td>ich_3.2.s.2.5</td><td>m3.2.s.2.5 process validation and/or evaluation</td></tr><tr><td>ich_3.2.s.2.6</td><td>m3.2.s.2.6 manufacturing process development</td></tr><tr><td>ich_3.2.s.3</td><td>m3.2.s.3 characterisation</td></tr><tr><td>ich_3.2.s.3.1</td><td>m3.2.s.3.1 elucidation of structure and other characteristics</td></tr><tr><td>ich_3.2.s.3.2</td><td>m3.2.s.3.2 impurities</td></tr><tr><td>ich_3.2.s.4</td><td>m3.2.s.4 control of drug substance</td></tr><tr><td>ich_3.2.s.4.1</td><td>m3.2.s.4.1 specification</td></tr><tr><td>ich_3.2.s.4.2</td><td>m3.2.s.4.2 analytical procedures</td></tr><tr><td>ich_3.2.s.4.3</td><td>m3.2.s.4.3 validation of analytical procedures</td></tr><tr><td>ich_3.2.s.4.4</td><td>m3.2.s.4.4 batch analyses</td></tr><tr><td>ich_3.2.s.4.5</td><td>m3.2.s.4.5 justification of specification</td></tr><tr><td>ich_3.2.s.5</td><td>m3.2.s.5 reference standards or materials</td></tr><tr><td>ich_3.2.s.6</td><td>m3.2.s.6 container closure system</td></tr><tr><td>ich_3.2.s.7</td><td>m3.2.s.7 stability</td></tr><tr><td>ich_3.2.s.7.1</td><td>m3.2.s.7.1 stability summary and conclusions</td></tr><tr><td>ich_3.2.s.7.2</td><td>m3.2.s.7.2 post-approval stability protocol and stability commitment</td></tr><tr><td>ich_3.2.s.7.3</td><td>m3.2.s.7.3 stability data</td></tr><tr><td>ich_3.2.p</td><td>m3.2.p drug product</td></tr><tr><td>ich_3.2.p.1</td><td>m3.2.p.1 description and composition of the drug product</td></tr><tr><td>ich_3.2.p.2</td><td>m3.2.p.2 pharmaceutical development</td></tr><tr><td>ich_3.2.p.2.1</td><td>m3.2.p.2.1 components of the drug product</td></tr><tr><td>ich_3.2.p.2.2</td><td>m3.2.p.2.2 drug product</td></tr><tr><td>ich_3.2.p.2.3</td><td>m3.2.p.2.3 manufacturing process development</td></tr><tr><td>ich_3.2.p.2.4</td><td>m3.2.p.2.4 container closure system</td></tr><tr><td>ich_3.2.p.2.5</td><td>m3.2.p.2.5 microbiological attributes</td></tr><tr><td>ich_3.2.p.2.6</td><td>m3.2.p.2.6 compatibility</td></tr><tr><td>ich_3.2.p.3</td><td>m3.2.p.3 manufacture</td></tr><tr><td>ich_3.2.p.3.1</td><td>m3.2.p.3.1 manufacturer(s)</td></tr><tr><td>ich_3.2.p.3.2</td><td>m3.2.p.3.2 batch formula</td></tr><tr><td>ich_3.2.p.3.3</td><td>m3.2.p.3.3 description of manufacturing process and process controls</td></tr><tr><td>ich_3.2.p.3.4</td><td>m3.2.p.3.4 controls of critical steps and intermediates</td></tr><tr><td>ich_3.2.p.3.5</td><td>m3.2.p.3.5 process validation and/or evaluation</td></tr><tr><td>ich_3.2.p.4</td><td>m3.2.p.4 control of excipients</td></tr><tr><td>ich_3.2.p.4.1</td><td>m3.2.p.4.1 specifications</td></tr><tr><td>ich_3.2.p.4.2</td><td>m3.2.p.4.2 analytical procedures</td></tr><tr><td>ich_3.2.p.4.3</td><td>m3.2.p.4.3 validation of analytical procedures</td></tr><tr><td>ich_3.2.p.4.4</td><td>m3.2.p.4.4 justification of specifications</td></tr><tr><td>ich_3.2.p.4.5</td><td>m3.2.p.4.5 excipients of human or animal origin</td></tr><tr><td>ich_3.2.p.4.6</td><td>m3.2.p.4.6 novel excipients</td></tr><tr><td>ich_3.2.p.5</td><td>m3.2.p.5 control of drug product</td></tr><tr><td>ich_3.2.p.5.1</td><td>m3.2.p.5.1 specification(s)</td></tr><tr><td>ich_3.2.p.5.2</td><td>m3.2.p.5.2 analytical procedures</td></tr><tr><td>ich_3.2.p.5.3</td><td>m3.2.p.5.3 validation of analytical procedures</td></tr><tr><td>ich_3.2.p.5.4</td><td>m3.2.p.5.4 batch analyses</td></tr><tr><td>ich_3.2.p.5.5</td><td>m3.2.p.5.5 characterisation of impurities</td></tr><tr><td>ich_3.2.p.5.6</td><td>m3.2.p.5.6 justification of specifications</td></tr><tr><td>ich_3.2.p.6</td><td>m3.2.p.6 reference standards or materials</td></tr><tr><td>ich_3.2.p.7</td><td>m3.2.p.7 container closure system</td></tr><tr><td>ich_3.2.p.8</td><td>m3.2.p.8 stability</td></tr><tr><td>ich_3.2.p.8.1</td><td>m3.2.p.8.1 stability summary and conclusion</td></tr><tr><td>ich_3.2.p.8.2</td><td>m3.2.p.8.2 post-approval stability protocol and stability commitment</td></tr><tr><td>ich_3.2.p.8.3</td><td>m3.2.p.8.3 stability data</td></tr><tr><td>ich_3.2.a</td><td>m3.2.a appendices</td></tr><tr><td>ich_3.2.a.1</td><td>m3.2.a.1 facilities and equipment</td></tr><tr><td>ich_3.2.a.2</td><td>m3.2.a.2 adventitious agents safety evaluation</td></tr><tr><td>ich_3.2.a.3</td><td>m3.2.a.3 excipients</td></tr><tr><td>ich_3.2.r</td><td>m3.2 r regional information</td></tr><tr><td>ich_3.3</td><td>m3.3 literature references</td></tr></table></li></ul></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode" : "brr"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
"valueInteger" : 2,
"_valueInteger" : {
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
"valueCanonical" : "http://hl7.org/fhir/us/pq-cmc-fda/ImplementationGuide/hl7.fhir.us.pq-cmc-fda"
}
]
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
"valueCode" : "trial-use",
"_valueCode" : {
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
"valueCanonical" : "http://hl7.org/fhir/us/pq-cmc-fda/ImplementationGuide/hl7.fhir.us.pq-cmc-fda"
}
]
}
}
],
"url" : "http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/cmc-comp-section-types-vs",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.4.642.40.36.48.2"
}
],
"version" : "2.0.0",
"name" : "CmcCompSectionTypesVS",
"title" : "eCTD sections Terminology",
"status" : "active",
"experimental" : false,
"date" : "2025-06-19T20:23:28+00:00",
"publisher" : "HL7 International / Biomedical Research and Regulation",
"contact" : [
{
"name" : "HL7 International / Biomedical Research and Regulation",
"telecom" : [
{
"system" : "url",
"value" : "http://www.hl7.org/Special/committees/rcrim"
},
{
"system" : "email",
"value" : "brr@lists.HL7.org"
}
]
}
],
"description" : "Value set of all codes in Code system PQCMC Comp Section Types.",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US",
"display" : "United States of America"
}
]
}
],
"compose" : {
"include" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/ICHContextOfUse",
"concept" : [
{
"code" : "ich_3.2.s",
"display" : "m3.2.s drug substance"
},
{
"code" : "ich_3.2.s.1",
"display" : "m3.2.s.1 general information"
},
{
"code" : "ich_3.2.s.2",
"display" : "m3.2.s.2 manufacture"
},
{
"code" : "ich_3.2.s.2.1",
"display" : "m3.2.s.2.1 manufacturer(s)"
},
{
"code" : "ich_3.2.s.2.2",
"display" : "m3.2.s.2.2 description of manufacturing process and process controls"
},
{
"code" : "ich_3.2.s.2.3",
"display" : "m3.2.s.2.3 control of materials"
},
{
"code" : "ich_3.2.s.2.4",
"display" : "m3.2.s.2.4 controls of critical steps and intermediates"
},
{
"code" : "ich_3.2.s.2.5",
"display" : "m3.2.s.2.5 process validation and/or evaluation"
},
{
"code" : "ich_3.2.s.2.6",
"display" : "m3.2.s.2.6 manufacturing process development"
},
{
"code" : "ich_3.2.s.3",
"display" : "m3.2.s.3 characterisation"
},
{
"code" : "ich_3.2.s.3.1",
"display" : "m3.2.s.3.1 elucidation of structure and other characteristics"
},
{
"code" : "ich_3.2.s.3.2",
"display" : "m3.2.s.3.2 impurities"
},
{
"code" : "ich_3.2.s.4",
"display" : "m3.2.s.4 control of drug substance"
},
{
"code" : "ich_3.2.s.4.1",
"display" : "m3.2.s.4.1 specification"
},
{
"code" : "ich_3.2.s.4.2",
"display" : "m3.2.s.4.2 analytical procedures"
},
{
"code" : "ich_3.2.s.4.3",
"display" : "m3.2.s.4.3 validation of analytical procedures"
},
{
"code" : "ich_3.2.s.4.4",
"display" : "m3.2.s.4.4 batch analyses"
},
{
"code" : "ich_3.2.s.4.5",
"display" : "m3.2.s.4.5 justification of specification"
},
{
"code" : "ich_3.2.s.5",
"display" : "m3.2.s.5 reference standards or materials"
},
{
"code" : "ich_3.2.s.6",
"display" : "m3.2.s.6 container closure system"
},
{
"code" : "ich_3.2.s.7",
"display" : "m3.2.s.7 stability"
},
{
"code" : "ich_3.2.s.7.1",
"display" : "m3.2.s.7.1 stability summary and conclusions"
},
{
"code" : "ich_3.2.s.7.2",
"display" : "m3.2.s.7.2 post-approval stability protocol and stability commitment"
},
{
"code" : "ich_3.2.s.7.3",
"display" : "m3.2.s.7.3 stability data"
},
{
"code" : "ich_3.2.p",
"display" : "m3.2.p drug product"
},
{
"code" : "ich_3.2.p.1",
"display" : "m3.2.p.1 description and composition of the drug product"
},
{
"code" : "ich_3.2.p.2",
"display" : "m3.2.p.2 pharmaceutical development"
},
{
"code" : "ich_3.2.p.2.1",
"display" : "m3.2.p.2.1 components of the drug product"
},
{
"code" : "ich_3.2.p.2.2",
"display" : "m3.2.p.2.2 drug product"
},
{
"code" : "ich_3.2.p.2.3",
"display" : "m3.2.p.2.3 manufacturing process development"
},
{
"code" : "ich_3.2.p.2.4",
"display" : "m3.2.p.2.4 container closure system"
},
{
"code" : "ich_3.2.p.2.5",
"display" : "m3.2.p.2.5 microbiological attributes"
},
{
"code" : "ich_3.2.p.2.6",
"display" : "m3.2.p.2.6 compatibility"
},
{
"code" : "ich_3.2.p.3",
"display" : "m3.2.p.3 manufacture"
},
{
"code" : "ich_3.2.p.3.1",
"display" : "m3.2.p.3.1 manufacturer(s)"
},
{
"code" : "ich_3.2.p.3.2",
"display" : "m3.2.p.3.2 batch formula"
},
{
"code" : "ich_3.2.p.3.3",
"display" : "m3.2.p.3.3 description of manufacturing process and process controls"
},
{
"code" : "ich_3.2.p.3.4",
"display" : "m3.2.p.3.4 controls of critical steps and intermediates"
},
{
"code" : "ich_3.2.p.3.5",
"display" : "m3.2.p.3.5 process validation and/or evaluation"
},
{
"code" : "ich_3.2.p.4",
"display" : "m3.2.p.4 control of excipients"
},
{
"code" : "ich_3.2.p.4.1",
"display" : "m3.2.p.4.1 specifications"
},
{
"code" : "ich_3.2.p.4.2",
"display" : "m3.2.p.4.2 analytical procedures"
},
{
"code" : "ich_3.2.p.4.3",
"display" : "m3.2.p.4.3 validation of analytical procedures"
},
{
"code" : "ich_3.2.p.4.4",
"display" : "m3.2.p.4.4 justification of specifications"
},
{
"code" : "ich_3.2.p.4.5",
"display" : "m3.2.p.4.5 excipients of human or animal origin"
},
{
"code" : "ich_3.2.p.4.6",
"display" : "m3.2.p.4.6 novel excipients"
},
{
"code" : "ich_3.2.p.5",
"display" : "m3.2.p.5 control of drug product"
},
{
"code" : "ich_3.2.p.5.1",
"display" : "m3.2.p.5.1 specification(s)"
},
{
"code" : "ich_3.2.p.5.2",
"display" : "m3.2.p.5.2 analytical procedures"
},
{
"code" : "ich_3.2.p.5.3",
"display" : "m3.2.p.5.3 validation of analytical procedures"
},
{
"code" : "ich_3.2.p.5.4",
"display" : "m3.2.p.5.4 batch analyses"
},
{
"code" : "ich_3.2.p.5.5",
"display" : "m3.2.p.5.5 characterisation of impurities"
},
{
"code" : "ich_3.2.p.5.6",
"display" : "m3.2.p.5.6 justification of specifications"
},
{
"code" : "ich_3.2.p.6",
"display" : "m3.2.p.6 reference standards or materials"
},
{
"code" : "ich_3.2.p.7",
"display" : "m3.2.p.7 container closure system"
},
{
"code" : "ich_3.2.p.8",
"display" : "m3.2.p.8 stability"
},
{
"code" : "ich_3.2.p.8.1",
"display" : "m3.2.p.8.1 stability summary and conclusion"
},
{
"code" : "ich_3.2.p.8.2",
"display" : "m3.2.p.8.2 post-approval stability protocol and stability commitment"
},
{
"code" : "ich_3.2.p.8.3",
"display" : "m3.2.p.8.3 stability data"
},
{
"code" : "ich_3.2.a",
"display" : "m3.2.a appendices"
},
{
"code" : "ich_3.2.a.1",
"display" : "m3.2.a.1 facilities and equipment"
},
{
"code" : "ich_3.2.a.2",
"display" : "m3.2.a.2 adventitious agents safety evaluation"
},
{
"code" : "ich_3.2.a.3",
"display" : "m3.2.a.3 excipients"
},
{
"code" : "ich_3.2.r",
"display" : "m3.2 r regional information"
},
{
"code" : "ich_3.3",
"display" : "m3.3 literature references"
}
]
}
]
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.